大行評級|麥格理:下調百威亞太目標價至12.9港元 維持“跑贏大市”評級
麥格理髮布研究報告指,百威亞太去年第四季收入按年跌11%,銷量按年跌12.7%,平均售價按年升1.9%。去年中國市佔率下跌149個基點,但銷售按年持平,農曆新年期間銷售增長正面,相比第四季有明顯改善。麥格理表示,集團派息率由2023年的82%升至103%,每股股息則由2023年的5.29美仙升至5.66美仙,意味着現金股息收益率爲5%,管理層希望透過維持或提高每年股息金額,實現股東總回報最大化。麥格理將集團今年淨利潤預測下調2.8%,明年則上調2.3%,同時將其目標價由13.4港元下調至12.9港元,維持其“跑贏大市”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.